Phone: (707) 546-5553
Email Us
1140 Sonoma Avenue 1-A
Santa Rosa, CA 95405

Uncategorized

It’s Men’s Health Month – Is prostate cancer prevention possible?

Urologist and prostate cancer specialist Dr. Michael Lazar talks about prevention and options for maintaining health after a cancer diagnosis. June is Men’s Health Month and the focus is on prostate cancer. Second only to skin cancer, prostate cancer is the most common cancer among men in the U.S. and the third most common cause [...]

June 26th, 2017|

Doctors believe it’s important to discuss pros and cons of prostate cancer screening with patients

A new study finds that while a blood test that helps to screen for prostate cancer remains common, only 30 percent of men in a large national survey reported having a balanced discussion of the advantages and disadvantages of the screening with their doctor. Moreover, having such a discussion of both pros and cons has [...]

April 24th, 2017|

New research reveals evidence linking inflammation to increased prostate cancer risk

Dr. Michael Lazar of California HIFU discusses the latest research on prostate cancer which offers hope for future treatments and may help to prevent the disease from becoming aggressive. An interesting new study, conducted by Dr. Andrew Goldstein, an assistant professor of molecular biology and a team of UCLA researchers, highlights a previously unrecognized type [...]

January 3rd, 2017|

California HIFU is the Right Choice for Prostate Cancer Treatment

For the past five years, Chris Lockheed’s PSA numbers had been going up. Then, last November, a biopsy revealed that he had two tumors on his prostate. Chris, 68, started doing research into what kind of options for treatment were available to him. When a radiation specialist in Rohnert Park told him about Dr. Michael [...]

August 2nd, 2016|

Study Supports Hemiablation HIFU for Prostate Cancer

Story source: Renal & Urology News. Jody A. Charnow, Editor. February 10, 2016 High-intensity focused ultrasound (HIFU) hemiablation offers mid-term promising functional and oncologic outcomes in carefully selected patients with clinically localized prostate cancer (PCa), according to researchers. In a prospective cohort study of 50 patients who underwent HIFU ablation of a single lobe of the prostate, [...]

February 25th, 2016|

Recently FDA approved HIFU for Prostate Cancer makes news in Kentucky

HIFU is making news all over the United States now that it has achieved FDA approval. In the news video below HIFU Prostate Services physician partner, Dr. John Jurige speaks with Louisville's news station, WHAS about HIFU for prostate cancer. Dr. Jurige treated the first patients in the US with HIFU outside of a clinical [...]

November 18th, 2015|

Validation of Focal Therapy for Prostate Cancer

From August 2015 Journal of Urology:  Study by New York University in which images from mpMRI identified prostate cancer before radical prostatectomy.  The pathologists then took the gland and did step-sections to pinpoint the actual tumor.  They found that a 9 mm "halo" of treatment around the imaged tumor boundaries would have covered 100% of [...]

September 17th, 2015|

“Because of HIFU and the compassionate care I received, I now have a new lease on life …”

July 2nd, 2015|

New High Intensity Focused Ultrasound Minimally-Invasive Treatment for Prostate Cancer Pioneered by Dr. Michael Lazar Soon to Be Approved by FDA for Use in the U.S.

The use of a new technology called High Intensity Focused Ultrasound (HIFU) waves to treat prostate cancer without surgery on an out-patient basis moves closer to U.S. approval thanks to Dr. Michael J. Lazar, Jr. and other urologists utilizing this next-generation technology with patients in other nations. HIFU technology achieves pinpoint accuracy using an “acoustic [...]

May 8th, 2015|

International HIFU Physician Dr. Michael Lazar

It has been very exciting to be able to offer HIFU to men with prostate cancer the past 6 years. The utility of the procedure continues to grow, with the evolution from merely whole gland therapy to the possibility of focal therapy. With MRI imaging improvements, we can not only limit treatment to the cancer [...]

May 7th, 2015|